|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
51834136
在线人数 :
1056
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"taiwanese secondary prevention"的相关文件
显示项目 1-8 / 8 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-03-08T08:29:23Z |
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
|
Hsuan, Chin-Feng; Lin, Fang-Ju; Lee, Thung-Lip; Yang, Kai-Chien; Tseng, Wei-Kung; Wu, Yen-Wen; Yin, Wei-Hsian; Yeh, Hung-I; Chen, Jaw-Wen; Wu, Chau-Chung; WEI-TIEN CHANG; Lee, Yi-Heng; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-12-22T03:54:12Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
JIANN-SHING JENG; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; Wu C.-C.; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-07-06T02:37:31Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; FANG-JU LIN; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
显示项目 1-8 / 8 (共1页)
1
每页显示[10|25|50]项目
|
